about
Perspectives in colorectal cancer.Precancerous lesions of the biliary tree.Regional cancer chemotherapy for advanced stage hepatocellular carcinoma.Modulation of fluoropyrimidines by leucovorin: rationale and status.Doxifluridine in advanced colorectal cancer.Developments of the fluoropyrimidines as inhibitors of thymidylate synthetase: pharmacologic and clinical aspects.Trends in epidemiology of colorectal cancer.Current questions related to an optimal treatment of colorectal liver metastases.Advanced colorectal cancer: impact of chemotherapy on survival.Sequential methotrexate/5-fluorouracil in advanced colorectal cancer treatment.Chemotherapy for patients not benefitting from 5-fluorouracil therapy.Clinical staging and pathological correlation in colorectal cancer.Radical surgery in rectal cancer patients: what does it mean today?DNA ploidy and cell kinetics in human colorectal carcinomas.Hepatic resection: when, what kind, and for which patients.Role of radiation therapy in the treatment of carcinoma of the rectum.Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas.Intracavitary therapy with bleomycin for the treatment of malignant pleural effusions.Surgical adjuvant therapy of non-small-cell lung cancer.Hormonal therapy for advanced prostatic carcinoma.Cisplatin-based chemotherapy of epithelial ovarian cancer.Gastric cancer: a neoplastic enigma.Hepatic regeneration and growth factors.Strategies in the study of hepatocellular carcinoma worldwide.Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: preliminary results.Non-surgical treatment of hepatocarcinoma.Systemic therapies for unresectable primary hepatic tumors.Medical treatment of hepatocellular carcinoma.Liver tumors in childhood: epidemiology and clinics.Rationale and results of the International Society of Pediatric Oncology (SIOP) Italian pilot study on childhood hepatoma: surgical resection d'emblée or after primary chemotherapy?Pediatric hepatic tumors: clinical trials conducted in the United States.New facts in the surgical treatment of Klatskin tumours.Hepatic tumor and tumor-like lesions in childhood.Surgical pathology of hepatobiliary malignancies.The role of angiography in hepatocellular carcinoma.Hepatitis viruses, cirrhosis, and liver cancer.Characterization of the hepatitis B virus transactivators: a possible direct role of the virus in the development of hepatocellular carcinoma.Hepatoma.Detection of preclinical hepatocellular carcinoma in patients with cirrhosis.Effect of treatment on clinical trials: chemoembolization.
P1433
Q33377198-73B5FDDE-FB8B-40D9-B20D-5DA7E4714A09Q34061545-3467D13B-9FC4-4C22-9FBF-A9C4A344F278Q34287165-9CC89CD2-38F3-4E66-950A-A0914FF0A17DQ37104099-C2229678-8ADA-45CA-BA3A-BF13D18A089AQ37104107-43C7041C-2B08-43D6-9DD3-DC9EF6580BC6Q37104115-CD60A8DD-64C4-42B6-9BCF-F1B51C9A0957Q37299748-A1989262-0996-48C0-9302-0DE936AB5B9BQ37299752-79F6EEA3-3CB6-4D1C-A5F1-90F07C994657Q37299760-5F597513-4BCE-4F5A-9D20-760A724A69A3Q37299763-8047DE74-EFB2-40E9-8D78-9CD965063C22Q37299769-775AF222-0029-4502-828C-E66F8E238365Q37299775-0F43EBAA-B9DA-4336-8367-75872647F6EBQ37299777-24D58E6E-4F70-400D-BBE2-51F23697D861Q37299783-19B139B6-F969-4505-ABED-29D65FA084AFQ37299787-0885735D-C886-421F-A858-56E6445757DFQ37355674-04EE4C77-C6DA-4CEF-8B3C-6209BE25327BQ37355677-41921DA1-CFB6-4C65-87E0-8B6E71858BC9Q38205982-1A99B91F-7C4F-4272-8DAA-7DAEB2F40CE5Q38284980-DC9C479D-1ADA-489C-B547-850E49026CC1Q38677261-A0002112-211F-4608-92A9-2F17A05AB3E1Q38677264-B87FA67B-3CB5-4342-A6E8-A4534D04F8D9Q38677269-954FACAE-703C-4967-B8A2-6FE4CFC4CD6FQ40487280-AF007D50-BB04-4B14-80F8-073827CEAF60Q40487287-E0F0C9A4-6E53-451C-AF82-D599EE820E77Q40753822-B89FB66F-F726-475F-8865-1CA570A10893Q40854453-0991C198-D7AE-4919-B385-37F857ACD1EDQ40854459-DD2416F5-CA81-4E67-8E4F-AC80E572DED9Q40854462-354DDCCD-17BC-45C5-A001-EE0D9E4629D0Q40854470-1EA0F93D-64DD-4EC7-9ACF-88C47094E29FQ40854477-3C9607A0-97D8-4533-9991-ADFD78D4AB46Q40854480-D4E15496-FEA0-4270-8631-955C28A4B172Q40854493-74DB3D77-E386-4143-A7CD-00A879A0965AQ40854497-67FAD9A3-5274-4840-95C1-EDC36B54AAF4Q40854505-75C88E49-D7D8-4216-B13F-760D60120DCCQ40854510-03A3E590-A2F1-44A3-B7C5-236187F3F3D4Q40854519-6D365B4E-11C1-4760-B047-7A0B89CDAD60Q40854526-A86B72A4-1BF6-4159-995A-F4C49B40EF5FQ40854532-CC0B81FD-C33C-4033-966F-9C40955A40AFQ40854537-C509AD6A-D25E-41E6-8D0E-6BC0E1852314Q40854543-75D79862-E5CC-45A8-9C7B-BCFC81E84933
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van John Wiley & Sons
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of surgical oncology. Supplement
@ast
Journal of surgical oncology. Supplement
@en
Journal of surgical oncology. Supplement
@es
Journal of surgical oncology. Supplement
@it
Journal of surgical oncology. Supplement
@nl
type
label
Journal of surgical oncology. Supplement
@ast
Journal of surgical oncology. Supplement
@en
Journal of surgical oncology. Supplement
@es
Journal of surgical oncology. Supplement
@it
Journal of surgical oncology. Supplement
@nl
altLabel
J Surg Oncol Suppl
@en
prefLabel
Journal of surgical oncology. Supplement
@ast
Journal of surgical oncology. Supplement
@en
Journal of surgical oncology. Supplement
@es
Journal of surgical oncology. Supplement
@it
Journal of surgical oncology. Supplement
@nl
P1055
P1156
P123
P1476
Journal of surgical oncology. Supplement
@en